WO2011109080A3 - A device for intranasal and extranasal neuromodulation - Google Patents

A device for intranasal and extranasal neuromodulation Download PDF

Info

Publication number
WO2011109080A3
WO2011109080A3 PCT/US2011/000379 US2011000379W WO2011109080A3 WO 2011109080 A3 WO2011109080 A3 WO 2011109080A3 US 2011000379 W US2011000379 W US 2011000379W WO 2011109080 A3 WO2011109080 A3 WO 2011109080A3
Authority
WO
WIPO (PCT)
Prior art keywords
nerve
methods
devices
neuromodulation
stimulation
Prior art date
Application number
PCT/US2011/000379
Other languages
French (fr)
Other versions
WO2011109080A2 (en
Inventor
Michael J. Partsch
Original Assignee
Partsch Michael J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Partsch Michael J filed Critical Partsch Michael J
Publication of WO2011109080A2 publication Critical patent/WO2011109080A2/en
Publication of WO2011109080A3 publication Critical patent/WO2011109080A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/36017—External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36071—Pain
    • A61N1/36075—Headache or migraine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36082—Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
    • A61N1/36085—Eating disorders or obesity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor

Abstract

Systems, devices and methods for treating a subject by neuromodulation of a nerve or nerve cluster accessible from the nasal cavity and/or sinuses. Described herein are systems, devices and methods for treating a patient (or for allowing a patient treat themselves) by stimulation of a nerve, such as the olfactory nerve. In one example, the system, methods and devices are for the treatment of obesity by stimulation of the olfactory nerve to generate a percept such as nausea, satiety, hunger, thirst, pain, discomfort, exhaustion, tiredness, exhilaration, happiness, anxiety, restlessness, calmness, peacefulness, anger, disinterest, satisfaction, aversion, or any combination of the above.
PCT/US2011/000379 2010-03-01 2011-02-28 A device for intranasal and extranasal neuromodulation WO2011109080A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30920310P 2010-03-01 2010-03-01
US61/309,203 2010-03-01

Publications (2)

Publication Number Publication Date
WO2011109080A2 WO2011109080A2 (en) 2011-09-09
WO2011109080A3 true WO2011109080A3 (en) 2012-01-19

Family

ID=44542768

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/000379 WO2011109080A2 (en) 2010-03-01 2011-02-28 A device for intranasal and extranasal neuromodulation

Country Status (1)

Country Link
WO (1) WO2011109080A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6108183B2 (en) * 2011-12-16 2017-04-05 コーデイト・メディカル・アクチエボラーグＣｈｏｒｄａｔｅ Ｍｅｄｉｃａｌ ＡＢ Device for stimulating the hypothalamus
EP2790632B1 (en) * 2011-12-16 2017-07-19 Chordate Medical AB Device for treatment of headache disorders
US11235146B2 (en) * 2014-12-10 2022-02-01 Spr Therapeutics, Inc. Apparatus and method for treating headaches
JP2020089723A (en) * 2018-12-07 2020-06-11 アヴェント インコーポレイテッド Device and method for selectively and reversibly modulating nervous system structure to inhibit perception of pain
US11896852B2 (en) 2020-12-21 2024-02-13 Xerox Corporation Closed-loop non-invasive transcranial stimulation and neural activity recording system and method

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060047325A1 (en) * 2004-07-26 2006-03-02 Mark Thimineur Stimulation system and method for treating a neurological disorder
US20060095088A1 (en) * 2004-10-21 2006-05-04 Dirk De Ridder New stimulation design for neuromodulation
US20070093870A1 (en) * 2005-10-25 2007-04-26 Cyberonics, Inc. Cranial nerve stimulation to treat eating disorders
US7529582B1 (en) * 1998-08-05 2009-05-05 Dilorenzo Biomedical, Llc Method and apparatus for neuromodulation and physiologic modulation for the treatment of metabolic and neuropsychiatric disease
US20100174329A1 (en) * 2009-01-02 2010-07-08 Cochlear Limited, IP Department Combined optical and electrical neural stimulation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7529582B1 (en) * 1998-08-05 2009-05-05 Dilorenzo Biomedical, Llc Method and apparatus for neuromodulation and physiologic modulation for the treatment of metabolic and neuropsychiatric disease
US20060047325A1 (en) * 2004-07-26 2006-03-02 Mark Thimineur Stimulation system and method for treating a neurological disorder
US20060095088A1 (en) * 2004-10-21 2006-05-04 Dirk De Ridder New stimulation design for neuromodulation
US20070093870A1 (en) * 2005-10-25 2007-04-26 Cyberonics, Inc. Cranial nerve stimulation to treat eating disorders
US20100174329A1 (en) * 2009-01-02 2010-07-08 Cochlear Limited, IP Department Combined optical and electrical neural stimulation

Also Published As

Publication number Publication date
WO2011109080A2 (en) 2011-09-09

Similar Documents

Publication Publication Date Title
PH12018501330A1 (en) Methods and systems for providing stimuli to the brain
WO2011109080A3 (en) A device for intranasal and extranasal neuromodulation
MY161168A (en) Transcutaneous stimulation method and system
GB201016812D0 (en) Method and apparatus for treating respiratory diesease
MX350378B (en) Enhancement of transport of therapeutic molecules across the blood brain barrier.
CA2863368A1 (en) Managing back pain by applying a high frequency electrical stimulus directly to the spinal cord
MX2011009752A (en) Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1.
WO2012054723A3 (en) Treatment of alpha-l-iduronidase (idua) related diseases by inhibition of natural antisense transcript to idua
WO2010129746A3 (en) Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp
MX339820B (en) Treatment of apolipoprotein-a1 related diseases by inhibition of natural antisense transcript to apolipoprotein-a1.
WO2014186453A3 (en) Apparatus and method for administering a medical device prescription
BR112012031617A2 (en) incontinence treatment
IN2012DN02325A (en)
WO2011163499A3 (en) Treatment of sodium channel, voltage-gated, alpha subunit (scna) related diseases by inhibition of natural antisense transcript to scna
GB2512765A (en) Devices and methods for promoting female sexual wellness
WO2010002936A3 (en) Systems, methods and devices for paired plasticity
WO2013138374A3 (en) Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf
MX2012000034A (en) Methods for treating or preventing fatigue.
WO2010093904A9 (en) Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf
WO2011011700A3 (en) Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
WO2012024478A3 (en) Treatment of nicotinamide phosphoribosyltransferase (nampt) related diseases by inhibition of natural antisense transcript to nampt
WO2010148065A3 (en) Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1
MX2009006672A (en) Combined effects of topiramate and ondansetron on alcohol consumption.
BRPI0904955A2 (en) Implantable drug depot to reduce, prevent or treat pain in a patient in need of such treatment and methods for treating acute pain and for making an implantable drug depot.
WO2011143640A3 (en) Treatment of par4 related diseases by inhibition of natural antisense transcript to par4

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11751016

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 11751016

Country of ref document: EP

Kind code of ref document: A2